Eli Lilly and Company
1,4-Oxazines useful as selective BACE1 inhibitors
Last updated:
Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, useful as a BACE1 inhibitor. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
18 Aug 2017
Issue date:
3 Sep 2019